
ExstoBio
Personalized medical cannabis solutions through precision cannabinoid therapeutics for targeted patient relief.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
* | N/A | Grant | |
Total Funding | 000k |
Related Content
ExstoBio Medicinal Cannabis is a pioneering company in the medical cannabis industry, focusing on the personalization of medical cannabis and the development of precision cannabinoid therapeutics. The company aims to set the standard of patient care by providing targeted relief through an integrated approach to medical cannabis care. ExstoBio serves patients who require medical cannabis for various health conditions, offering them customized treatment plans that enhance their quality of life and reduce pain levels with minimal adverse effects. Operating in the medicinal cannabis market, ExstoBio's business model revolves around developing and distributing precision cannabinoid products that are tailored to individual patient needs. The company generates revenue through the sale of these specialized medical cannabis products and services, which are recommended by healthcare professionals. By leveraging advanced research and development in cannabinoid therapeutics, ExstoBio ensures high adherence to treatment plans and significant improvements in patient outcomes.
Keywords: medical cannabis, precision therapeutics, patient care, personalized treatment, cannabinoid products, healthcare, pain relief, quality of life, advanced R&D, targeted relief.